Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Operating Expenses | 4,898 | 6,263 | 15,617 | 5,431 | 9,335 |
| Operating Income | -4,898 | -6,263 | -15,617 | -5,431 | -9,335 |
| Other Income | 669 | 1,150 | 883 | 685 | 181 |
| Pre-tax Income | -4,229 | -5,113 | -14,734 | -4,746 | -9,154 |
| Net Income Continuous | -4,229 | -5,113 | -14,734 | -4,746 | -9,154 |
| Net Income | $-4,229 | $-5,113 | $-14,734 | $-4,746 | $-9,154 |
| EPS Basic Total Ops | -0.60 | -0.70 | -2.20 | -0.70 | -1.40 |
| EPS Basic Continuous Ops | -0.56 | -0.67 | -2.12 | -0.72 | -1.39 |
| EPS Diluted Total Ops | -0.60 | -0.70 | -2.20 | -0.70 | -1.40 |
| EPS Diluted Continuous Ops | -0.56 | -0.67 | -2.12 | -0.72 | -1.39 |
| EBITDA(a) | $-4,578 | $-6,001 | $-15,388 | $-5,178 | $-9,190 |